Showing posts with label IPO. Show all posts
Showing posts with label IPO. Show all posts

Syrma SGS Technology IPO Dates, Review, Price, IPO Allotment Details,Latest GMP & Market Lot


Syrma SGS Technology IPO
date is fixed yet, the IPO is to open on August 12 and will close on August 18, 2022. Syrma SGS IPO to raise around Rs.840 crores via IPO that comprises fresh issue of Rs.766 crores and offer for sale up to 3,369,360 equity shares of Rs.10 each. The retail quota is 35%, QIB is 50%, and HNI is 15%.


Syrma SGS Technology Limited is a technology-focused engineering and design company engaged in turnkey electronics manufacturing services (EMS). The company is based in Chennai, incorporated in 2004. Syrma provides high-mix, flexible volume, precision OEM manufacturing. They are one-stop-solution electronics manufacturing services (EMS) including product design, quick prototyping, PCB assembly,  Box build, repair & rework, and automatic tester development services. Syrma SGS also offers OEM solutions for RFID tags & inlays and high-frequency magnetic components. We serve global OEMs in 20+ countries and have supplied several hundreds of million units.


The product portfolio includes Printed circuit board assemblies (PCBA), Radio frequency identification (RFID) products, Electromagnetic and electromechanical parts, Motherboards, Memory products - DRAM modules, solid state, USB drives. They have manufacturing facilities in Himachal Pradesh, Haryana, Uttar Pradesh, Tamil Nadu and Karnataka. They have dedicated R&D facilities in Chennai, Gurgaon and in Stuttgart, Germany too. You can check Syrma SGS Technology IPO subscription status and Syrma SGS Technology IPO allotment status on their respective pages. Syrma SGS Technology raised Rs.252 crores from anchor investors, ahead of IPO on August 11, 2022.


Syrma SGS Technology IPO Review (Good or Bad)

  • Apply


Brokerage Firm IPO Review

  • Capital Market: May Apply
  • Axis Bank: Not Rated
  • KR Choksey: Apply
  • Canara Bank: Apply
  • Choice Broking: May Apply
  • Hem Securities: Apply
  • Reliance Securities: Apply

Syrma SGS IPO Details

Subscription Dates12 – 18 August 2022
Price BandINR209 – 220 per share
Fresh issueINR766 crore
Offer For Sale3,369,360 shares (INR70.42 – 74.13 crore)
Total IPO sizeINR836.42 – 840.13 crore
Minimum bid (lot size)68 shares
Face Value INR10 per share
Retail Allocation35%
Listing OnNSE, BSE

Syrma SGS Technology Company Financial Report

 Rs. in Crores

Revenue(Rs.)Expense(Rs.)PAT(Rs.)
201935733020.97
202040534743.88
202144440828.60
2022
65560730.69

Syrma SGS Technology IPO Market Lot

The Syrma SGS Technology IPO minimum market lot is 68 shares with Rs.14,960 application amount. The retail investors can apply up-to 13 lots with 884 shares or Rs.194,480 amount.

Syrma SGS Technology IPO Allotment & Listing Dates

The Syrma SGS Technology IPO date is August 12 and the close date is August 18. The Syrma SGS Technology IPO allotment will be finalized on August 23 and the IPO listing on August 26.

Peer Group

  • Dixon Technologies Limited
  • Amber Enterprises India Limited

Company Promoters

  • Sandeep Tandon
  • Jasbir Singh Gujral
  • Veena Kumari Tandon
  • Tancom Electronics Private Limited


Syrma SGS Technology IPO Registrar

Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: syrma.ipo@linkintime.co.in
Website: https://linkintime.co.in/

Syrma SGS Technology IPO Allotment Status Check

Check Syrma SGS Technology IPO allotment status on Linkintime website allotment URL. Click Here

Syrma SGS Technology IPO Lead Managers

  • DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
  • ICICI Securities Limited
  • IIFL Securities Ltd

Company Address

Syrma SGS Technology Ltd
Plot B27, Phase II, Zone B,
MEPZ-SEZ, Sanatorium, Tambaram,
Chennai 600 045
Phone: 022 40363000
Email: compliance@syrmasgs.com
Website: https://syrmasgs.com/

Share:

Glenmark Life Sciences IPO Dates, Review, Price, IPO Allotment Details & Market Lot

Glenmark Life Sciences IPO to hit the market on 27 July 2021 and closes on 29 July 2021. The company plans to raise Rs.15515 crore through the initial public offerings. Glenmark Life Sciences is an API arm of Glenn Mark Pharma, a leading drug maker. They are one of the leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs). They are making high-quality drugs by unlocking the possibilities of science. They created the strong relationship with leading pharmaceutical companies that have helped us expand our product offerings and geographic reach. They have 120 API in their catalogue. They supply their API to 540 pharma companies in India and overseas. They export their products in Europe, Latin America, North America, Japan, and the rest of the world. Check out Glenmark Life Sciences IPO details.


Important Details:
According to the DRHP, the proceeds from the IPO will be used for:
  • Payment of outstanding purchase consideration to the promoter for the spin-off of the API businessb)
  •  Funding capital expenditure requirements
  • General corporate purposes

How to apply in Share Holder Quota:
If you want to apply Glenmark Life Sciences IPO in the share holder quota, you should buy at least 1 share of Glenmark Pharma. It should be in your demat account when the company announce their IPO date or before RHP.
Note: According to RHP there is no Share Holders Quota.

Glenmark Life Sciences IPO Date & Price Band

 IPO Open: 27 July 2021
 IPO Close: 29 July 2021
 IPO Size: Approx Rs.1514 Crores
 Fresh Issue: Approx Rs.1060 Crores
 Offer for Sale: Approx Rs.454 Crores, 63,00,000 Shares
 Face Value: Rs.Per Equity Share
 Price Band: Rs.695 to Rs.720 Per Share
 Listing on: BSE & NSE
 Retail Portion: 35%
 Equity: Shares

Glenmark Life Sciences IPO Market Lot

The Glenmark Life Sciences IPO minimum market lot is 20 shares with Rs.14,400 application amount. The retail investors can apply up-to 13 lots with 260 shares or Rs.187,200 amount.
 
 Minimum Lot Size: Minimum 20 Shares
 Minimum Amount: Rs.14,400
 Maximum Lot Size: Maximum 260 Shares
 Maximum Amount: Rs.187,200

Glenmark Life Sciences IPO Date, Time Table, Allotment & Listing

The Glenmark Life Sciences IPO date is 27 July 2021 and the IPO close date is 29 July 2021. The allotment date is 03 August 2021 and the IPO may list on 06 August 2021.
 
 Basis of Allotment: 27 July 2021
 Basis of Allotment: 29 July 2021
 Basis of Allotment: 03 August 2021
 Refunds: 04 August 2021
 Credit to Demat Account: 05 August 2021
 Listing Date: 06 August 2021

Glenmark Life Sciences IPO Form

How to apply the Glenmark Life Sciences IPO? You can apply Glenmark Life Sciences IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Glenmark Life Sciences IPO in the Invest section. The other option you can apply Glenmark Life Sciences IPO via IPO forms download via NSE and BSE. Check out the Glenmark Life Sciences forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.

Glenmark Life Sciences Company Financial Report

  Rs. in Crores

RevenueExpensesPAT
20180.250.26-0.43
2019886.87658.59195.59
20201549.301128.24313.10
2021 9M
1418.471088.15246.90

Subscriptions

CategoryShares OfferedDay 1Day 2Day 3
QIB42,42,3790.001.3936.97
NII32,32,7700.853.40122.54
Retail75,43,1305.179.2814.63
Total1,50,18,2792.785.7844.17

Company Promoters

  • Glenmark Pharmaceuticals Limited

Glenmark Life Sciences IPO Registrar

KFin Technologies Private Limited (Formerly known as
Karvy Fintech Private Limited)
Selenium Tower-B
Plot No-31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500032
Telangana, India
Tel: +91 40 6716 2222
E-mail: glenmark.ipo@kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221

Note: Glenmark Life Sciences IPO allotment status on KFintech website allotment URL.
 Click Here

Glenmark Life Sciences IPO Lead Managers

  • Kotak Mahindra Capital Company Limited
  • BofA Securities India Limited
  • Goldman Sachs (India) Securities Private Limited
  • DAM Capital Advisors Limited
  • BOB Capital Markets Limited
  • SBI Capital Markets Limited

Company Address

Glenmark Life Sciences Limited
Registered Office:
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213, Maharashtra
Corporate Office:
Glenmark House, B. D. Sawant Marg,
Andheri (East), Mumbai 400099,
Maharashtra, India
Tel: +912189 234456/ +912189 234246
Website: www.glenmarklifesciences.com
Contact Person: Rudalf Corriea
(Company Secretary and Compliance Officer)
E-mail: complianceofficer@glenmarklifesciences.com
Share:

Tatva Chintan Pharma IPO Dates, Review, Price, IPO Allotment Details & Market Lot


Tatva Chintan Pharma IPO may hit the market on 16th July 2021. The company to raise Rs.450 via initial public offer that comprises Rs.225 crore of fresh issue and Rs.225 crore of offer for sale. Tatva Chintan Pharma Chem Limited incorporated in 1996 based in Gujarat. They are manufacturer of chestructure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. They are one of the largest manufacturer of SDAs for zeolites in India. The industries they serve are automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. They provide their products to India and overseas. The export revenues is around 75% and more for the company. They have 2 manufacturing facilities  at Ankleshwar and Dahej in Gujarat. The few of the big names are their customer and the names are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories.Check out Tatva Chintan Pharma IPO details.

Tatva Chintan Pharma IPO Review
  • Apply with Short Term & Long Term Gain

Brokerage Firm IPO Reviews

  • Axis Capital: Neutral
  • Capital Market: May Apply
  • Investmentz: Apply
  • KR Choksey Securities: Apply
  • Motilal Oswal: Apply
  • Reliance Securities: Apply
  • Sharekhan: Neutral
  • Ventura Securities: Apply

Tatva Chintan Pharma IPO allotment status will be available on Link Intime’s website. 

Click on this link to get allotment status.


Tatva Chintan Pharma IPO Date & Price Band
 IPO Open: 16 July 2021
 IPO Close: 20 July 2021
 IPO Size: Approx Rs.450 Crores
 Fresh Issue: Approx Rs.225 Crores
 Offer for Sale: Approx Rs.225 Crores
 Face Value: Rs.10 Per Equity Share
 Price Band: Rs.1073 to Rs.1083 Per Share
 Listing on: BSE & NSE
 Retail Portion: 35%
 Equity: - Shares
 Discount: N/A
Tatva Chintan Pharma IPO Market Lot
The Tatva Chintan Pharma IPO minimum market lot is 13 shares with Rs.14,079 application amount. The retail investors can apply up-to 13 lots with 182 shares or Rs.197,106 amount.
 Minimum Lot Size: Minimum 13 Shares
 Minimum Amount: Rs.14,079
 Maximum Lot Size: Maximum 182 Shares
 Maximum Amount: Rs.197,106
Tatva Chintan Pharma IPO Allotment & Listing
The Tatva Chintan Pharma IPO date is 16 July 2021 and the close date is 20 July 2021. The allotment date is 26 July 2021 and the IPO to list on 29 July 2021.
 Basis of Allotment: 26 July 2021
 Refunds: 27 July 2021
 Credit to Demat Account: 28 July 2021
 Listing Date: 29 July 2021
Tatva Chintan Pharma IPO Form
How to apply the Tatva Chintan Pharma IPO? You can apply Tatva Chintan Pharma IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Tatva Chintan Pharma IPO in the Invest section. The other option you can apply Tatva Chintan Pharma IPO via IPO forms download via NSE and BSE. Check out the Tatva Chintan Pharma forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.

Tatva Chintan Pharma Company Financial Report
  Rs. in Crores

AssetsRevenuesPAT
201814413712.29
201918820720.54
202024926737.79
2021 - 9M
27619531.14
Tatva Chintan Pharma Subscription
CategoryShares offeredSubscription (no. of times, at 5 PM)
Day 1Day 2Day 3
QIB9,31,9660.511.97185.23
NII6,98,9751.1312.21512.22
Retail16,30,9418.2523.7535.35
Total32,61,8824.5115.05180.36


Company Promoters
  • Ajaykumar Mansukhlal Patel
  • Chintan Nitinkumar Shah
  • Snehkar Rasiklal Somani

Tatva Chintan Pharma IPO Registrar
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: tatva.ipo@linkintime.co.in
Website: http://www.linkintime.co.in

Note: Check Tatva Chintan Pharma IPO allotment status on Linkintime website allotment URL. Click Here

Tatva Chintan Pharma IPO Lead Managers
  • ICICI Securities Ltd
  • JM Financial Consultants Private Limited

Company Address
Tatva Chintan Pharma Chem Limited
Plot No. 502 / 17, GIDC Estate, Ankleshwar,
Bharuch, Gujarat - 393002, India
Phone: +91 75730 46951
Email: cs@tatvachintan.com
Website: http://www.tatvachintan.com/
Share:
X

Get Updates on Facebook

Like our Page. Become a FAN!

Contact Us

Recent Posts